These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11891 related articles for article (PubMed ID: 10025678)

  • 81. Nevi and melanoma induced by chemical carcinogens in laboratory animals: similarities and differences with human lesions.
    Pawlowski A; Lea PJ
    J Cutan Pathol; 1983 Apr; 10(2):81-110. PubMed ID: 6406571
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Tumor imaging with monoclonal antibodies.
    Bischof Delaloye A; Delaloye B
    Semin Nucl Med; 1995 Apr; 25(2):144-64. PubMed ID: 7597418
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Malignant melanoma in a primary care pathologico-anatomical laboratory in 1988 and the freckle bus year].
    Bosch MM; Boon ME
    Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2051-4. PubMed ID: 2234179
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Inhibition of growth of B16 melanoma caused by liver regeneration].
    Zarković N; Zarković K; Jurin M; Ilić Z; Zgradić I; Danilović Z; Gezo A
    Lijec Vjesn; 1990; 112(3-4):80-5. PubMed ID: 2398779
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Adenocarcinoma of the larynx--a distant metastasis from a rectal primary.
    Hilger AW; Prichard AJ; Jones T
    J Laryngol Otol; 1998 Feb; 112(2):199-201. PubMed ID: 9578888
    [TBL] [Abstract][Full Text] [Related]  

  • 86. P16 protein expression in primary cutaneous melanoma with positive and negative lymph node biopsies: Particular aspects of a study performed at the Hospital de Clinicas de Porto Alegre, Brazil.
    Fauri J; Ricardi F; Diehl E; Cartell A; Furian R; Bakos L; Edelweiss M
    Can J Plast Surg; 2011; 19(3):77-81. PubMed ID: 22942654
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Monoclonal antibody against a melanosomal protein in melanotic and amelanotic human melanoma cells.
    McEwan M; Parsons PG; Moss DJ; Burrows S; Stenzel D; Bishop CJ; Strutton GM
    Pigment Cell Res; 1989; 2(1):1-7. PubMed ID: 2470076
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Potential CNS antitumor agents-phenothiazines II: fluphenazine analogs.
    Hirata T; Peng G; Driscoll JS
    J Pharm Sci; 1978 Feb; 67(2):157-62. PubMed ID: 621629
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Recruiting donors for autopsy based cancer research.
    Thombs J; Borthwick NJ; Hungerford JL; Cree IA
    J Med Ethics; 2005 Jun; 31(6):360-1. PubMed ID: 15923487
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Radiation and melanoma: response of B16 mouse tumor cells and clonal lines to in vitro irradiation.
    Hill HZ; Hill GJ; Miller CF; Kwong F; Purdy J
    Radiat Res; 1979 Nov; 80(2):259-76. PubMed ID: 504576
    [No Abstract]   [Full Text] [Related]  

  • 91. Effects on syngeneic tumors of F1 lymphocytes sensitized in vitro by parental stimulator cells.
    Havelaar IJ; McCullough CS; Sugarbaker PH
    Oncology; 1985; 42(3):179-86. PubMed ID: 3873633
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Prognostic factor analysis for multiple brain metastases after gamma knife radiosurgery: results in 97 patients.
    Schoeggl A; Kitz K; Ertl A; Reddy M; Bavinzski G; Schneider B
    J Neurooncol; 1999 Apr; 42(2):169-75. PubMed ID: 10421075
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Antitumor agents. 25. Synthesis and antitumor activity of uracil and thymine alpha-methylene-gamma-lactones and related derivatives.
    Lee KH; Wu YS; Hall IH
    J Med Chem; 1977 Jul; 20(7):911-4. PubMed ID: 874966
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Analysis of nuclear DNA and morphometry, and proliferating cell nuclear antigen in primary and metastatic malignant melanoma.
    Björnhagen V; Lindholm J; Auer G
    Scand J Plast Reconstr Surg Hand Surg; 1997 Jun; 31(2):109-18. PubMed ID: 9232695
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Protection of melanoma cells against superoxide radicals by melanins.
    Schwabe K; Lassmann G; Damerau W; Naundorf H
    J Cancer Res Clin Oncol; 1989; 115(6):597-600. PubMed ID: 2558119
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Review of ubenimex (Bestatin): clinical research.
    Ota K
    Biomed Pharmacother; 1991; 45(2-3):55-60. PubMed ID: 1912370
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Thrombin receptor activation results in calcium signaling and protein kinase C-dependent stimulation of DNA synthesis in HEp-2g laryngeal carcinoma cells.
    Kaufmann R; Schafberg H; Rudroff C; Nowak G
    Cancer; 1997 Dec; 80(11):2068-74. PubMed ID: 9392328
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Treatment of stage IV malignant melanoma with dacarbazine, carmustine, cisplatin, and tamoxifen regimens: a University of South Florida and H. Lee Moffitt Melanoma Center Study.
    Saba HI; Cruse CW; Wells KE; Klein CJ; Reintgen DS
    Ann Plast Surg; 1992 Jan; 28(1):65-9. PubMed ID: 1642409
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Aberrant apoptotic machinery confers melanoma dual resistance to BRAF(V600E) inhibitor and immune effector cells: immunosensitization by a histone deacetylase inhibitor.
    Jazirehi AR; Nazarian R; Torres-Collado AX; Economou JS
    Am J Clin Exp Immunol; 2014; 3(1):43-56. PubMed ID: 24660121
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Melanomas of the lower extremity among native Puerto Ricans.
    Pantoja E; Llobet RE; Roswit B
    Cancer; 1976 Sep; 38(3):1420-3. PubMed ID: 953976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 595.